The monitoring of hypocalcaemia improved significantly; 83.3% (n=5) of patients who were at an intermediate risk of hypocalcaemia (PTH 0.6-1.6) had 12 hourly calcium monitoring for 48 hours compared to 22.2% prior to the QI project. The gene discussed is PTH; the disease is Hypocalcemia.